Home vs. Hospital Care for Mild Sudden Pancreas Inflammation
Part of Digestive system clinical trials.
This trial compares whether patients with mild acute pancreatitis (sudden pancreas inflammation) can safely recover at home with outpatient visits instead of staying in the hospital. The goal is to see if home care is as effective and safe as inpatient care for patients with mild cases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with acute pancreatitis confirmed by blood tests (lipase or amylase levels) or imaging, plus characteristic abdominal pain
- Mild pancreatitis only: no signs of organ dysfunction or systemic inflammation at emergency department arrival
- Able to eat and drink normally at the time of enrollment
- Have a responsible adult caregiver available at home to help monitor you
- Live within 30–45 minutes' drive of the hospital and able to receive phone calls for follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares placing a small plastic drain (stent) in your pancreas duct versus usual care for people with severe acute pancreatitis that is starting to cause organ failure. The goal is to see if the stent helps you heal faster and prevents complications.
This study looks at whether an upper endoscopy (a camera test to look inside your stomach and the first part of your small intestine) done within 24-48 hours of being admitted to the hospital can help guide treatment for acute pancreatitis. You may be able to join if you are an adult with a confirmed case of acute pancreatitis and are able to safely undergo this procedure.
This trial tests a special cooling catheter placed in the body to reduce inflammation during severe pancreatitis. It may help patients who are sick enough to need hospital care but have not had pancreatitis before or other major health issues.
This study tests whether heparin, a blood-thinning medication, can help prevent organ damage in people with acute pancreatitis (sudden severe pancreas inflammation). Researchers believe heparin may reduce the risk of serious complications like organ failure.
This study tests whether giving IV fluids based on how your heart responds can improve recovery from acute pancreatitis, compared with usual care. It may help your body handle fluids better during treatment.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
Hear when a new Acute Pancreatitis (AP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.